Search results
Results From The WOW.Com Content Network
Lisinopril. Lisinopril is a medication belonging to the drug class of angiotensin-converting enzyme (ACE) inhibitors and is used to treat hypertension (high blood pressure), heart failure, and heart attacks. [7] For high blood pressure it is usually a first-line treatment. It is also used to prevent kidney problems in people with diabetes ...
List of potential long-term side effects. hyperprolactinemia causes impotence in males. [16] Hyponatremia low sodium blood levels. There has been a study that suggests antipsychotics are associated with possible cortical reconfiguration and gray matter loss, but correlational data also suggests patients who consume antipsychotics, like people ...
This is a partial list of herbs and herbal treatments with known or suspected adverse effects, either alone or in interaction with other herbs or drugs. Non-inclusion of an herb in this list does not imply that it is free of adverse effects.
The Ray-Ban Meta glasses have a new ability to livestream directly to Meta platforms. You can start a live video and hand off the camera angle between your phone and glasses with a click.
Fenfluramine as a single drug was first introduced in the 1970s, but was not popular because it only temporarily reduced weight. [1] A 1984 study found a weight loss of 7.5 kg on average in 24 weeks, as compared to 4.4 kg under placebo. [4] It sold modestly until the 1990s, when it was combined with phentermine and heavily marketed.
Nearly 45,000 children received care for pink eye at a doctor's office, eye clinic or emergency room and 69% were prescribed antibiotics, which come in drops and ointments.
The researchers suggested either diet or long-term supplementation. According to another review in Cureus, omega-3s improved memory, cognitive well-being, and blood flow in the brain. These ...
Ray-Ban is a brand of luxury sunglasses and eyeglasses created in 1936 by Bausch & Lomb. The brand is best known for its Wayfarer and Aviator lines of sunglasses. In 1999, Bausch & Lomb sold the brand to Italian eyewear conglomerate Luxottica Group for a reported $640 million.